Kittipibul, V., Mentz, R. J., Young, R., Butler, J., Ezekowitz, J. A., Lam, C. S. P., Ponikowski, P., Voors, A., Corda, S., McMullan, C., O’Connor, C. M., Anstrom, K. J., Armstrong, P. W., & VICTORIA Study Group. (2024). Projecting the benefit of vericiguat in PARADIGM-HF and DAPA-HF populations: Insights from the VICTORIA trial. ESC heart failure, 10.1002/ehf2.15134. Advance online publication. https://doi.org/10.1002/ehf2.15134
